Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Ferroptosis nanomedicine: scientific challenges and alternatives for modulating tumor metabolic and immunological panorama. ACS Nano. 2023;17:15328–53.
Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603–8.
Liang C, Zhang X, Yang M, Dong X. Latest progress in ferroptosis inducers for most cancers remedy. Adv Mater. 2019;31:e1904197.
Zhu P, Pu YY, Wang M, Wu WC, Qin HL, Shi JL. MnOOH-catalyzed autoxidation of glutathione for reactive oxygen species manufacturing and nanocatalytic tumor innate immunotherapy. J Am Chem Soc. 2023;145:5803–15.
Li SL, Chu X, Dong HL, Hou HY, Liu Y. Latest advances in augmenting Fenton chemistry of nanoplatforms for enhanced chemodynamic remedy. Coordin Chem Rev. 2023;479:215004.
Zheng JS, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32:920–37.
Liang DG, Minikes AM, Jiang XJ. Ferroptosis on the intersection of lipid metabolism and mobile signaling. Mol Cell. 2022;82:2215–27.
Zhu XY, Wu JB, Liu RX, Xiang HD, Zhang WQ, Chang QC, Wang SS, Jiang R, Zhao F, Li QQ, et al. Engineering single-atom iron nanozymes with radiation-enhanced self-cascade catalysis and self-supplied H2O2 for radio- enzymatic remedy. ACS Nano. 2022;16:18849–62.
Yang ZR, Yang CY, Yang D, Zhang Y, Yang QZ, Qu FY, Guo W. L-arginine-modified CoWO4/FeWO4 S-Scheme heterojunction enhances ferroptosis towards strong tumor. Adv Healthc Mater. 2023;12:e2203092.
Fan Q, Xiong W, Zhou H, Yang J, Feng J, Li Z, Wu L, Hu F, Duan X, Li B, et al. An AND logic gate for magnetic-resonance-imaging-guided ferroptosis remedy of tumors. Adv Mater. 2023;35:e2305932.
Yang J, Feng J, Yang S, Xu Y, Shen Z. Exceedingly small magnetic iron oxide nanoparticles for T(1) -weighted magnetic resonance imaging and imaging-guided remedy of tumors. Small. 2023;19:e2302856.
Li YL, Wang XL, Ding BB, He C, Zhang C, Li JT, Wang HN, Li ZB, Wang G, Wang YW, et al. Synergistic Apoptosis-Ferroptosis: oxaliplatin loaded amorphous iron oxide nanoparticles for high-efficiency remedy of orthotopic pancreatic most cancers and CA19-9 ranges lower. Chem Eng J. 2023;464:142690.
Du JH, Zhou MT, Chen Q, Tao YC, Ren J, Zhang Y, Qin HL. Disrupting intracellular iron homeostasis by engineered metal-organic framework for nanocatalytic tumor remedy in synergy with autophagy amplification-promoted ferroptosis. Adv Funct Mater. 2023;33:2215244.
Kudarha R, Dhas N, Mutalik S. Distinct options of iron primarily based metallic natural frameworks (MOFs) for ferroptosis mediated most cancers remedy: a complete evaluation. Coordin Chem Rev. 2023;494:215330.
Xie WS, Guo ZH, Zhao LY, Wei Y. Steel-phenolic networks: facile assembled complexes for most cancers theranostics. Theranostics. 2021;11:6407–26.
Li J, Zhou Y, Liu J, Yang X, Zhang Okay, Lei L, Hu H, Zhang H, Ouyang L, Gao H. Steel-phenolic networks with ferroptosis to ship NIR-responsive CO for synergistic remedy. J Management Launch. 2022;352:313–27.
Shan X, Li S, Solar B, Chen Q, Solar J, He Z, Luo C. Ferroptosis-driven nanotherapeutics for most cancers therapy. J Management Launch. 2020;319:322–32.
Zhang WX, Li Y, Ke D, Gao YR, Fei T, Wang GQ, Shu Y, Wang JH. GSH-depleting metal-polyphenol-network nanoparticles with twin enzyme actions induce enhanced ferroptosis. Biomater Sci. 2023;11:6906–18.
Li Y, Fan WZ, Gu X, Liu SP, He TT, Gou SQ, Meng WL, Li M, Liu XH, Ren Y et al. Biodegradable ferric phosphate nanocarriers with tumor-specific activation and glutathione depletion for tumor self-enhanced ferroptosis and chemotherapy. Adv Funct Mater. 2024; 2313540.
Gao D, Asghar S, Hu RF, Chen S, Niu RX, Liu J, Chen ZP, Xiao YY. Latest advances in various nanosystems for nitric oxide supply in most cancers remedy. Acta Pharm Sin B. 2023;13:1498–521.
Zhao ZQ, Shan XZ, Zhang HY, Shi XB, Huang PQ, Solar J, He ZG, Luo C, Zhang SW. Nitric oxide-driven nanotherapeutics for most cancers therapy. J Management Launch. 2023;362:151–69.
Wu Y, Xie HL, Li YP, Bao XY, Lu GL, Wen JY, Gao Y, Li YP, Zhang ZW. Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to enhance intratumor supply and chemotherapy of albumin-bound paclitaxel nanoparticles. Nano Lett. 2023;23:939–47.
Wen LW, Liu HY, Hu C, Wei ZX, Meng Y, Lu CX, Su YH, Lu LG, Liang H, Xu QB, et al. Thermoacoustic imaging-guided thermo-chemotherapy for hepatocellular carcinoma sensitized by a microwave-responsive nitric oxide nanogenerator. ACS Appl Mater Interfaces. 2023;15:10477–91.
Yu WJ, Jia F, Fu JZ, Chen YH, Huang Y, Jin Q, Wang YX, Ji J. Enhanced transcutaneous chemodynamic remedy for melanoma therapy by cascaded Fenton-like reactions and nitric oxide supply. ACS Nano. 2023;17:15713–23.
He M, Music YY, Xu W, Zhang XL, Dong CM. 4 birds with one stone: a multifunctional polypeptide nanocomposite to unify ferroptosis, nitric oxide, and photothermia for amplifying antitumor immunity. Adv Funct Mater. 2023;33:2304216.
Wang CY, Tian G, Yu X, Zhang X. Latest advances in practical nanomaterials for catalytic technology of nitric oxide: a mini evaluation. Small. 2023;19:e2207261.
Yu J, Zhang RL, Chen BH, Liu XL, Jia Q, Wang XF, Yang Z, Ning PB, Wang ZL, Yang Y. Injectable reactive oxygen species-responsive hydrogel dressing with sustained nitric oxide launch for bacterial ablation and wound therapeutic. Adv Funct Mater. 2022;32:2202857.
Wang Y, Tang QS, Wu RQ, Solar SH, Zhang JX, Chen J, Gong M, Chen CY, Liang XL. Ultrasound-triggered piezocatalysis for selectively managed NO fuel and chemodrug launch to reinforce drug penetration in pancreatic most cancers. ACS Nano. 2023;17:3557–73.
Shi H, Xiong CF, Zhang LJ, Cao HC, Wang R, Pan P, Guo HY, Liu T. Gentle-triggered nitric oxide nanogenerator with excessive L-arginine loading for synergistic photodynamic/fuel/photothermal remedy. Adv Healthc Mater. 2023;12:e2300012.
Li G, Lu X, Zhang S, Zhang J, Fu X, Zhang M, Teng L, Solar F. Multi-enzyme cascade-triggered nitric oxide launch nanoplatform mixed with chemo starvation-like remedy for multidrug-resistant cancers. ACS Appl Mater Interfaces. 2023;15:31285–99.
Chen X, Li JY, Roy S, Ullah Z, Gu JS, Huang HY, Yu C, Wang XJ, Wang H, Zhang YH et al. Improvement of polymethine dyes for NIR-II fluorescence imaging and remedy. Adv Healthc Mater. 2024:e2304506.
Liang JT, Li L, Tian HL, Wang ZH, Liu GW, Duan XR, Guo MW, Liu JQ, Zhang W, Good EC, et al. Drug repurposing-based brain-targeting self-assembly nanoplatform utilizing enhanced ferroptosis towards glioblastoma. Small. 2023;19:e2303073.
Wang Okay, Jiang L, Qiu L. Close to infrared gentle triggered ternary synergistic most cancers remedy through L-arginine-loaded nanovesicles with modification of PEGylated indocyanine inexperienced. Acta Biomater. 2022;140:506–17.
Prince Y, Hiremath N, Vankayala R. Close to-infrared gentle activatable niosomes loaded with indocyanine inexperienced and plasmonic gold nanorods for theranostic purposes. Biomater Sci. 2023;11:7759–67.
Wu H, Wang C, Solar J, Solar L, Wan J, Wang S, Gu D, Yu C, Yang C, He J, et al. Self-assembled and self-monitored sorafenib/indocyanine inexperienced nanodrug with synergistic antitumor exercise mediated by hyperthermia and reactive oxygen species-induced apoptosis. ACS Appl Mater Interfaces. 2019;11:43996–4006.
Wang X, Li H, Meng F, Luo L. Bioadhesive metal-phenolic nanoparticles for enhanced NIR imaging-guided locoregional photothermal/antiangiogenic remedy. J Mater Chem B. 2021;9:4710–7.
Wang H, Hu H, Yang H, Li Z. Hydroxyethyl starch primarily based sensible nanomedicine. RSC Adv. 2021;11:3226–40.
Chen J, Zhang Z, Li Y, Zeng H, Li Z, Wang C, Xu C, Deng Q, Wang Q, Yang X, et al. Exact fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based sensible nanomedicine for enhanced antitumor efficacy. J Mater Chem B. 2022;10:8193–210.
Aparecida Stahl M, Luisa Ludtke F, Grimaldi R, Lucia Gigante M, Paula Badan Ribeiro A. Characterization and stability of alpha-tocopherol loaded strong lipid nanoparticles formulated with completely different totally hydrogenated vegetable oils. Meals Chem. 2024;439:138149.
Li S, Chen C, Zhang Z, Wang D, Lv S. Illustration and utility of enhancing impact of arginine on interactions between nano-clays: self-healing hydrogels. Delicate Matter. 2019;15:303–11.
Liu ZD, Liu SA, Liu B, Bian YL, Yuan M, Yang CZ, Meng Q, Chen CX, Ma PA, Lin J. Fe(III)-naphthazarin metal-phenolic networks for glutathione-depleting enhanced ferroptosis-apoptosis mixed most cancers remedy. Small. 2023;19:e2207825.
Feng W, Shi W, Wang Z, Cui Y, Shao X, Liu S, Rong L, Liu Y, Zhang H. Enhancing tumor remedy of Fe(III)-shikonin supramolecular nanomedicine through triple ferroptosis amplification. ACS Appl Mater Interfaces. 2022;14:37540–52.
Mo ZM, Li QT, Zhao Okay, Xu Q, Hu H, Chen X, Luo YX, Chi B, Liu LP, Fang XF, et al. A nanoarchitectonic method allows triple modal synergistic therapies to reinforce antitumor results. ACS Appl Mater Interfaces. 2022;14:10001–14.
Shi H, Wang R, Cao HC, Guo HY, Pan P, Xiong CF, Zhang LJ, Yang Q, Wei S, Liu T. A metal-polyphenol-based oxygen economizer and Fenton response amplifier for self-enhanced synergistic photothermal/chemodynamic/chemotherapy. Adv Healthc Mater. 2023;12:e2300054.
Mao GP, Xin DD, Wang Q, Lai DM. Sodium molybdate inhibits the expansion of ovarian most cancers cells through inducing each ferroptosis and apoptosis. Free Radical Bio Med. 2022;182:79–92.
Kagan VE, Mao GW, Qu F, Angeli JPF, Doll S, St Croix C, Dar HH, Liu B, Tyurin VA, Ritov VB, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81–90.
Quiroga J, Alarcon P, Manosalva C, Taubert A, Hermosilla C, Hidalgo MA, Carretta MD, Burgos RA. Glycolysis and mitochondrial operate regulate the unconventional oxygen species manufacturing induced by platelet-activating consider bovine polymorphonuclear leukocytes. Vet Immunol Immunopathol. 2020;226:110074.
Lahooti B, Akwii RG, Zahra FT, Sajib MS, Lamprou M, Alobaida A, Lionakis MS, Mattheolabakis G, Mikelis CM. Focusing on endothelial permeability within the EPR impact. J Management Launch. 2023;361:212–35.